•
Sep 30, 2021

OptimizeRx Q3 2021 Earnings Report

Total Revenue
$16.1M
Previous year: $10.5M
+53.3%
EPS
$0.09
Previous year: $0.07
+28.6%
Gross Profit
$9.08M
Previous year: $6.01M
+50.9%
Cash and Equivalents
$85.1M
Previous year: $12M
+606.9%
Free Cash Flow
$186K
Previous year: -$127K
-246.6%
Total Assets
$135M
Previous year: $55.1M
+144.2%

OptimizeRx

OptimizeRx